Biolyn Pharmaceutical B.V.
Tirzepatide pharmaceutical vial
In Stock
CAS: 2023788-19-2

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist peptide. Biolyn supplies research-grade and API-grade Tirzepatide to qualified pharmaceutical developers and research institutions.

Technical Profile

A 39-amino acid synthetic peptide with a C20 fatty diacid moiety. Acts as a dual incretin receptor agonist with preferential GIP receptor activity.

CAS Number2023788-19-2
Molecular Weight4,813.45 g/mol
Molecular FormulaC225H348N48O68
Purity>99% (HPLC)
FormLyophilized Powder
Storage-20C, desiccated, protected from light
Applications
GIP/GLP-1 dual agonist researchMetabolic syndrome studiesPharmaceutical formulation (B2B)Preclinical developmentType 2 diabetes research
SemaglutideMT-II (Melanotan II)
Biolyn Pharmaceutical B.V.
Age Verification & Research Use

Please confirm before you continue

Biolyn Pharmaceutical B.V. supplies products strictly to businesses and institutions for laboratory and research use. Our products are not for human or veterinary consumption.

  • I am at least 18 years of age.
  • I represent a business, research institution, or licensed manufacturer.
  • I understand all products are supplied for laboratory and research purposes only — not for human or veterinary consumption.

By entering you accept our research-use terms. B2B only. No retail / No B2C.